During insertion of the sheath within an optease retrieval filter kit, the distal end of the sheath became frayed.Therefore, it was replaced with a new optease and it could be inserted.There was no reported patient injury.The device will not be returned for analysis because of an emergent procedure.An approach was made from the femoral artery.The product appeared normal when taken from its packaging.There was no difficulty flushing or assembling the devices.The access site was not a chronic total occlusion (cto) and did not have any stenosis.There was no excessive force used to insert the sheath.A dilator was used prior to inserting the sheath.The product appeared normal when taken from its packaging.There was no difficulty flushing or assembling the devices.The access site was not a chronic total occlusion (cto) and did not have any stenosis.There was no excessive force used to insert the sheath.A dilator was used prior to inserting the sheath.
|
During insertion of the sheath within an optease retrieval filter kit, the distal end of the sheath became frayed.Therefore, it was replaced with a new optease and it could be inserted.There was no reported patient injury.The device will not be returned for analysis because of an emergent procedure.An approach was made from the femoral artery.The product appeared normal when taken from its packaging.There was no difficulty flushing or assembling the devices.The access site was not a chronic total occlusion (cto) and did not have any stenosis.There was no excessive force used to insert the sheath.A dilator was used prior to inserting the sheath.The product was not returned for analysis.A review of the device history record revealed no anomalies during the manufacturing and inspection processes that can be associated with the reported complaint.Without the return of the product for analysis, the event reported by the customer as ¿brite tip (csi/filters)- frayed/split/torn¿ could not be confirmed.Procedural factors, (such as interaction of the cannula sheath with a concomitant vessel dilator or guide wire) may contribute to the failure as reported.According to the instructions for use (ifu), ¿a vessel dilator facilitates the percutaneous entry of the csi by forming an atraumatic transition from the skin through the subcutaneous tissue to the vessel.If increased resistance is felt upon insertion of the csi, investigate the cause before continuing.If the cause of the resistance cannot be determined and corrected, discontinue the procedure and withdraw the csi.¿ based on the device history record review, there is no indication that the event is related to the device manufacturing process.Therefore, no corrective or preventative actions will be taken at this time.
|